Antibiotics for common respiratory tract infections in adults

Archives of Internal Medicine

Volumn 162, Issue 3, 2002, Pages 256-264

  Hirschmann, J V ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DEXTROMETHORPHAN; DOXYCYCLINE; OXYMETAZOLINE; PENICILLIN DERIVATIVE; XYLOMETAZOLINE;

ANTIBIOTIC THERAPY; ASTHMA; BRONCHITIS; CHRONIC BRONCHITIS; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG INDUCED DISEASE; HUMAN; PATIENT SATISFACTION; PHARYNGITIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SINUSITIS; TREATMENT OUTCOME;

EID: 0037059950     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.3.256     Document Type: Review

References (155)

1. Recent advances in medicine
2. Trends in antimicrobial drug prescribing among office-based physicians in the United States
3. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians
4. Antibiotics and upper respiratory infection: Do some folks think there is a cure for the common cold?
5. Antibiotics and respiratory infections: Are patients more satisfied when expectations are met?
6. Prevalence and resistance mechanisms of common bacterial respiratory pathogens
7. Epidemiology of drug resistance: Implications for a post-antimicrobial era
8. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
9. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci
10. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis
11. Acute bronchitis: Course of symptoms and restrictions in patients' daily activities
12. Production of tracheobronchitis in volunteers with rhinovirus in a small-particle aerosol
13. The Tecumseh study of respiratory illness, II: Patterns of occurrence of infection with respiratory pathogens, 1965-1969
14. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients
15. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
16. Acute bronchitis in the community: Clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine
17. Mycoplasma pneumoniae infections in University of Wisconsin students
18. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population
19. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients
20. Acute bronchitis in adults: How close do we come to its ætiology in general practice?
21. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis
22. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M catarrhalis from sputum
23. Spread of Streptococcus pneumoniae in families, I: Carriage rates and distribution of types
24. Haemophilus influenzae infections in adults: Report of nine cases and review of the literature
25. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole
26. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis
27. Effectiveness of erythromycin in the treatment of acute bronchitis
28. Erythromycin in the treatment of acute bronchitis in a community practice
29. Doxycycline in acute bronchitis: A randomized double-blind trial
30. Randomised controlled trial of antibiotics in patients with cough and purulent sputum
31. Effects of doxycycline in patients with acute cough and purulent sputum: A double blind placebo controlled trial
32. Evaluation and treatment of respiratory infections: Does managed care make a difference?
33. Current management of acute bronchitis in ambulatory care: The use of antibiotics and bronchodilators
34. Randomized placebo-controlled trials of antibiotics for acute bronchitis: A critical review of the literature
35. Treatment of acute bronchitis in adults without underlying lung disease
36. Antibiotics in acute bronchitis: A meta-analysis
37. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults
38. The treatment of cough: A comprehensive review
39. Albuterol delivered by metered-dose inhaler to treat acute bronchitis
40. Symptomatic effect of inhaled fenoterol in acute bronchitis: A placebo-controlled double-blind study
41. Respiratory viruses and exacerbations of asthma in adults
42. Respiratory tract viral infections in inner-city asthmatic adults
43. Relationship of bacterial and viral infections to exacerbations of asthma
44. Viral and bacterial infections in adults with chronic asthma
45. Association of viral and mycoplasma infections with exacerbations of asthma
46. Acute exacerbations of asthma in adults: Role of Chlamydia pneumoniae infection
47. Chlamydia pneumoniae and asthma
48. Chlamydia pneumoniae and exacerbations of asthma in adults
49. Transtracheal aspiration studies in asthmatic patients in relapse with "infective" asthma and in subjects without respiratory disease
50. How general practitioners manage acute asthma attacks
51. Randomised comparison of guided self management and traditional treatment of asthma over one year
52. Acute asthma: Emergency department management and prospective evaluation of outcome
53. Routine antibiotics in hospital management of acute asthma
54. Guidelines for the management of asthma
55. Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema
56. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis
57. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease
58. Chlamydia pneumoniae infection in acute exacerbations of COPD
59. Role of infection in chronic bronchitis
60. A study of infective and other factors in exacerbations of chronic bronchitis
61. Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis
62. Exacerbations of chronic bronchitis: Treatment with oxytetracycline
63. Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis
64. Bacteriological findings in the transtracheal aspirate from patients with acute exacerbation of chronic bronchitis
65. Bacterial infection in chronic obstructive pulmonary disease: A study of stable and exacerbated outpatients using the protected specimen brush
66. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis: Use of the protected specimen brush technique in 54 mechanically ventilated patients
67. Pilot study of factors associated with exacerbations in chronic bronchitis
68. Chronic obstructive airway disease: Bacterial and cellular content of the sputum
69. Haemophilus influenzae and Haemophilus parainfluenzae in chronic obstructive pulmonary disease
70. Do bacteria cause exacerbations of COPD?
71. Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis
72. Antibiotic regimes in chronic bronchitis
73. A controlled study of the effect of treatment on chronic bronchitis: An evaluation using pulmonary function tests
74. Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis
75. Antibiotic therapy of acute exacerbations of chronic bronchitis: A controlled study using tetracycline
76. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
77. Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis: A double-blind, placebo-controlled multicentre study in general practice
78. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice
79. Antibiotics in chronic obstructive pulmonary disease exacerbations: A meta-analysis
80. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
81. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency
82. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
83. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
84. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation
85. The effect of erythromycin on resolution of symptoms among adults with pharyngitis not caused by group A streptococcus
86. Rational decision making based on history: Adult sore throats
87. Pharyngitis in adults: The presence and coexistence of viruses and bacterial organisms
88. Transportability of a decision rule for the diagnosis of streptococcal pharyngitis
89. Clinical spectrum of pharyngeal gonococcal infection
90. Prevalence of pharyngeal gonorrhea in general medical patients with sore throats
91. Recognition of streptococcal pharyngitis in adults
92. Bacterial flora in patients presenting with sore throat in Dutch general practice
93. The importance of disease prevalence in transporting clinical prediction rules: The case of streptococcal pharyngitis
94. Treatment of acute streptococcal pharyngitis and prevention of acute rheumatic fever: A statement for health professionals
95. Group A streptococcal infections and acute rheumatic fever
96. An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention
97. Penicillin in sore throat
98. Open randomised trial of prescribing strategies in managing sore throat
99. Treatment of acute sore throat with penicillin: A controlled trial in young soldiers
100. Comparative effects of penicillin, aureomycin and terramycin on streptococcal tonsillitis and pharyngitis
101. Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis
102. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice
103. Penicillin for acute sore throat: Randomised double blind trial of seven days versus three days treatment or placebo in adults
104. Penicillin in acute tonsillitis, phlegmonous tonsillitis and ulcerative tonsillitis
105. A controlled trial of erythromycin in adults with nonstreptococcal pharyngitis
106. Does antimicrobial therapy of streptococcal pharyngitis or pyoderma alter the risk of glomerulonephritis?
107. Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis
108. Antibiotics, sore throats and acute nephritis
109. Poststreptococcal glomerulonephritis: Current clinical and pathologic concepts
110. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: The medicalising effect of prescribing antibiotics
111. Care must be taken when extrapolating data
112. A randomized trial for outpatient management of peritonsillar abscess
113. Managing sore throat: A literature review, II: Do antibiotics confer benefit?
114. Diagnosis and management of group A streptococcal pharyngitis: A practice guideline
115. Are antibiotics appropriate for sore throats? costs outweigh the benefits
116. A perspective on penicillin allergy
117. Nationwide survey of Kawasaki disease and acute rheumatic fever
118. Monitoring trends in acute rheumatic fever in the United States
119. Rheumatic fever
120. Antibiotics, sore throats and rheumatic fever
121. A community-wide study of acute rheumatic fever in adults: Epidemiologic and preventive factors
122. Rheumatic fever in Rochester, Minnesota, 1935-1978
123. The return of acute rheumatic fever in young adults
124. Erythromycin therapy of respiratory infections, I: Controlled studies on the comparative efficacy of erythromycin and penicillin in scarlet fever
125. Computed tomographic study of the common cold
126. Acute community-acquired sinusitis
127. Bacteriological findings of acute maxillary sinusitis in young adults
128. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR
129. Clinical evaluation for sinusitis: Making the diagnosis by history and physical examination
130. Randomised, double-blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults
131. Predicting acute maxillary sinusitis in a general practice population
132. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: Comparison with computed tomography
133. Analysis of symptoms and clinical signs in the maxillary sinus empyema
134. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis
135. The therapeutic effects of cyclacillin in acute sinusitis: In vitro and in vivo correlations in a placebo-controlled study
136. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial
137. Double-blind trial of doxicycline in acute maxillary sinusitis: A clinical and bacteriological study
138. Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut-off points in sinus CT
139. Patients' willingness to take risks in the management of pharyngitis
140. Uncomfortable prescribing decisions: A critical incident study
141. Antibiotics and respiratory infections: Are patients more satisfied when expectations are met?
142. A study of the relationship between patients' attitudes and doctors' prescribing
143. Prescribing and referral in general practice: A study of patients' expectations and doctors' actions
144. Are patients more satisfied when they receive a prescription? The effect of patient expectations in general practice
145. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: Questionnaire study
146. Prescribing behaviour in clinical practice: Patients' expectations and doctors' perceptions of patients' expectations - A questionnaire study
147. Do physicians take into account patients' expectations?
148. Treatment of upper respiratory infections: Do patients really want antibiotics?
149. Patient satisfaction with an office visit for the common cold
150. Patient expectations and satisfaction with medical care for upper respiratory infections
151. Characteristics and experiences of parents and adults who want antibiotics for cold symptoms
152. Antibiotics and the adult sore throat - An unnecessary ceremony
153. What's in a name? Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis